ZA881053B - Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration - Google Patents
Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administrationInfo
- Publication number
- ZA881053B ZA881053B ZA881053A ZA881053A ZA881053B ZA 881053 B ZA881053 B ZA 881053B ZA 881053 A ZA881053 A ZA 881053A ZA 881053 A ZA881053 A ZA 881053A ZA 881053 B ZA881053 B ZA 881053B
- Authority
- ZA
- South Africa
- Prior art keywords
- compounds
- prostaglandin
- derivatives
- pharmaceutical compositions
- active agents
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 150000003165 prostaglandin E1 derivatives Chemical class 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873704825 DE3704825A1 (de) | 1987-02-16 | 1987-02-16 | Prostaglandin e1-derivate als pharmazeutische wirkstoffe und diese verbindungen enthaltende arzneimittel insbesondere zur transkutanen anwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA881053B true ZA881053B (en) | 1988-08-12 |
Family
ID=6321070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA881053A ZA881053B (en) | 1987-02-16 | 1988-02-16 | Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0292643B1 (OSRAM) |
| JP (1) | JPS63246331A (OSRAM) |
| AT (1) | ATE80616T1 (OSRAM) |
| AU (2) | AU623336B2 (OSRAM) |
| CA (1) | CA1327359C (OSRAM) |
| DE (2) | DE3704825A1 (OSRAM) |
| DK (1) | DK173552B1 (OSRAM) |
| ES (1) | ES2043696T3 (OSRAM) |
| GR (1) | GR3005743T3 (OSRAM) |
| HU (1) | HU199687B (OSRAM) |
| ZA (1) | ZA881053B (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2939569A (en) * | 1957-10-16 | 1960-06-07 | Gay W Roach | Cotton weighing machine |
| EP0634172A4 (en) * | 1993-02-03 | 1995-08-02 | Teijin Ltd | COMPOSITION FOR DERMATOLOGICAL PREPARATION CONTAINING PROSTACYCLINE AS ACTIVE INGREDIENT. |
| US5656663A (en) * | 1993-02-03 | 1997-08-12 | Teijin Limited | External skin treatment agent composition containing isocarbacyclins as active ingredient |
| US6007836A (en) * | 1993-05-28 | 1999-12-28 | Vericade, Inc. | Transdermal vasodilator |
| FR2812191B1 (fr) * | 2000-07-28 | 2003-10-17 | Oreal | Utilisation d'agonistes du recepteur des prostaglandines e2 (ep-3) pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques |
| FR2812192B1 (fr) * | 2000-07-28 | 2003-01-31 | Oreal | Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils |
| FR2812190B1 (fr) * | 2000-07-28 | 2003-01-31 | Oreal | Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils |
| FR2812193B1 (fr) * | 2000-07-28 | 2003-10-24 | Oreal | Utilisation d'antagoniste des recepteurs des prostaglandines ep-2 et/ou ep-4 pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques |
| AU2004227853A1 (en) * | 2003-04-02 | 2004-10-21 | Nexmed (Holdings), Inc. | Prostaglandin compositions and their use for the treatment of vasospasm |
| IT1402047B1 (it) * | 2010-10-19 | 2013-08-28 | Cross Pharma Sa | Uso del mexiprostil nel trattamento delle malattie infiammatorie intestinali |
| US8940794B2 (en) | 2011-04-07 | 2015-01-27 | Nexmed Holdings, Inc. | Methods and compositions for treating Raynaud's disease |
| US10383839B2 (en) | 2011-06-30 | 2019-08-20 | Johnson & Johnson Vision Care, Inc. | Esters for treatment of ocular inflammatory conditions |
| ITRM20120036A1 (it) * | 2012-02-02 | 2013-08-03 | Robert Davis Steigerwalt Jr | Applicazione transdermica di prostaglandina e1 per il trattamento dell¿ischemia oculare. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3735005A (en) * | 1970-08-19 | 1973-05-22 | Alza Corp | Method for preparing a viable platelet concentrate |
| US4205178A (en) * | 1976-12-30 | 1980-05-27 | The Upjohn Company | 6-Keto prostaglandin E-type compounds |
| AU511711B2 (en) * | 1976-12-30 | 1980-09-04 | Upjohn Company, The | 6-Oxo and 5, 6-Dihalo prostaglandin analogues |
| JPS6022710B2 (ja) * | 1977-09-16 | 1985-06-03 | 小野薬品工業株式会社 | プロスタグランジン類似化合物 |
| JPS59216820A (ja) * | 1983-05-20 | 1984-12-06 | Taisho Pharmaceut Co Ltd | プロスタグランジン脂肪乳剤 |
| US4707495A (en) * | 1985-10-28 | 1987-11-17 | Ortho Pharmaceutical | Peptic ulcer treatment method |
-
1987
- 1987-02-16 DE DE19873704825 patent/DE3704825A1/de not_active Withdrawn
-
1988
- 1988-02-15 EP EP88102189A patent/EP0292643B1/de not_active Expired - Lifetime
- 1988-02-15 DE DE88102189T patent/DE3874610D1/de not_active Expired - Lifetime
- 1988-02-15 JP JP63032571A patent/JPS63246331A/ja active Pending
- 1988-02-15 ES ES88102189T patent/ES2043696T3/es not_active Expired - Lifetime
- 1988-02-15 AT AT88102189T patent/ATE80616T1/de not_active IP Right Cessation
- 1988-02-15 DK DK198800775A patent/DK173552B1/da not_active IP Right Cessation
- 1988-02-16 AU AU11766/88A patent/AU623336B2/en not_active Ceased
- 1988-02-16 HU HU88742A patent/HU199687B/hu not_active IP Right Cessation
- 1988-02-16 CA CA000559004A patent/CA1327359C/en not_active Expired - Fee Related
- 1988-02-16 ZA ZA881053A patent/ZA881053B/xx unknown
-
1992
- 1992-04-24 AU AU15184/92A patent/AU649130B2/en not_active Ceased
- 1992-09-17 GR GR920402069T patent/GR3005743T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0292643A1 (de) | 1988-11-30 |
| HUT46224A (en) | 1988-10-28 |
| DK77588A (da) | 1988-08-17 |
| JPS63246331A (ja) | 1988-10-13 |
| DK173552B1 (da) | 2001-02-26 |
| GR3005743T3 (OSRAM) | 1993-06-07 |
| DE3874610D1 (OSRAM) | 1992-10-22 |
| CA1327359C (en) | 1994-03-01 |
| ATE80616T1 (de) | 1992-10-15 |
| DK77588D0 (da) | 1988-02-15 |
| AU1518492A (en) | 1992-06-25 |
| AU649130B2 (en) | 1994-05-12 |
| ES2043696T3 (es) | 1994-01-01 |
| AU623336B2 (en) | 1992-05-14 |
| DE3704825A1 (de) | 1988-08-25 |
| EP0292643B1 (de) | 1992-09-16 |
| AU1176688A (en) | 1988-08-18 |
| HU199687B (en) | 1990-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0279149A3 (en) | Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same | |
| FI872864A0 (fi) | Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
| IL89748A (en) | Pharmaceutical compositions for systemic transdermal administration, containing deprenyl | |
| IE894048L (en) | New therapeutically active compound and a process for its¹preparation | |
| HUT47217A (en) | Process for producing pharmaceutical compositions containing indol derivatives as active components | |
| MY102038A (en) | 4-substituted androstendione derivatives and process for their preparation | |
| TW234691B (OSRAM) | ||
| IL108071A0 (en) | Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them | |
| ZA881053B (en) | Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration | |
| ATE173627T1 (de) | Medizinische zusammensetzung | |
| IL68456A0 (en) | Pharmaceutical compositions comprising perfluorohydrocarbons as vehicles | |
| HUT38097A (en) | Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances | |
| CS734389A3 (en) | 4-fluoro-2-//(4-methoxy-2-pyridyl)methyl/sulfinyl/ -1h - benzimidazole, process for its production and a pharmaceutical comprising said compound as an active component | |
| AU2617288A (en) | Pharmaceutical formulations for transdermal administration | |
| IE56229B1 (en) | 2-piperazinyl-or-homopiperazinyl-quinazoline derivatives their production and pharmaceutical compositions containing them | |
| ES8203349A1 (es) | Un procedimiento para la preparacion de 1,2-bis(nicotinami- do) propano | |
| GB1351437A (en) | N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity | |
| GB1535778A (en) | Compounds useful in treatment of unipolar depression | |
| SE7708622L (sv) | 2-bensyl-perhydroazepiner, sett for framstellning derav och lekemedel, innehallande dem | |
| MX9305578A (es) | Adsorbato a base de una mezcla de sustancias auxiliares y un principio activo no solido para la produccion de preparados medicamentosos. | |
| DE3372772D1 (en) | Quinazolinone derivatives, process for their preparation and their use in medicaments | |
| GB1465771A (en) | Pharmaceutical composition and use thereofd | |
| JO1531B1 (en) | New near-compounds | |
| JO1519B1 (en) | New compounds (new benzimidazole derivatives are effective as ulcers) | |
| FR2567755B1 (fr) | Nouveau medicament anti-tumoral contenant comme ingredient actif le triacetoxy-1,8,9 anthracene |